Second, to assess whether alloreactive T cells specific to the B6 host are important for eliminating tumors, B6 CD4+ T cells were stimulated with BALB/c GM-DCs and injected into B16F1 melanoma cells. The gene discussed is CD4; the disease is melanoma.